As expected, steroid hormone receptors, including glucocorticoids receptor, NR3C1, express in non-TNBC breast cancer (Supplementary Fig. 1F) in contrast to TNBC where glucocorticoids receptor is predominant (Fig. 1C). This evidence concerns the gene NR3C1 and breast carcinoma.